日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report

儿童弥漫性内生性脑桥胶质瘤患儿接受伏立诺他联合放疗及维持治疗的I/II期临床试验：儿童肿瘤协作组报告

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noab188
Su, Jack M; Kilburn, Lindsay B; Mansur, David B; Krailo, Mark; Buxton, Allen; Adekunle, Adesina; Gajjar, Amar; Adamson, Peter C; Weigel, Brenda; Fox, Elizabeth; Blaney, Susan M; Fouladi, Maryam
胶质瘤
肿瘤
肿瘤免疫
神经科学
发表日期：2022
文献求助 收藏

Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)

克唑替尼治疗ALK异常复发/难治性神经母细胞瘤患者的疗效：儿童肿瘤协作组研究（ADVL0912）

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-4224
Foster, Jennifer H; Voss, Stephan D; Hall, David C; Minard, Charles G; Balis, Frank M; Wilner, Keith; Berg, Stacey L; Fox, Elizabeth; Adamson, Peter C; Blaney, Susan M; Weigel, Brenda J; Mossé, Yael P
ALK
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)

克唑替尼联合细胞毒性化疗治疗难治性实体瘤或间变性大细胞淋巴瘤（ALCL）患儿的安全性、耐受性和药代动力学：儿童肿瘤协作组 1 期联合研究（ADVL1212）

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-020-04171-4
Greengard, Emily; Mosse, Yael P; Liu, Xiaowei; Minard, Charles G; Reid, Joel M; Voss, Stephan; Wilner, Keith; Fox, Elizabeth; Balis, Frank; Blaney, Susan M; Adamson, Peter C; Weigel, Brenda J
肿瘤
肿瘤免疫
淋巴瘤
细胞生物学
毒理研究
发表日期：2020
文献求助 收藏

Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)

一项针对患有难治性/复发性实体瘤（包括尤文氏肉瘤）的儿童和青少年的 1/2 期试验，评估他拉唑帕尼联合替莫唑胺的疗效：儿童肿瘤协作组 1 期联盟研究 (ADVL1411)

期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.28073
Schafer, Eric S; Rau, Rachel E; Berg, Stacey L; Liu, Xiaowei; Minard, Charles G; Bishop, Alexander J R; Romero, J Carolina; Hicks, M John; Nelson, Marvin D Jr; Voss, Stephan; Reid, Joel M; Fox, Elizabeth; Weigel, Brenda J; Blaney, Susan M
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Current Activities of the Coalition of Cancer Cooperative Groups

癌症合作组织联盟的当前活动

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djy190
Bertagnolli, Monica M; Blaney, Susan M; Blanke, Charles D; Curran, Walter J; Dancey, Janet; Mannel, Robert S; O'Dwyer, Peter J; Schnall, Mitchell D; Wolmark, Norman
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group

儿童肿瘤协作组报告：对培门冬酶过敏的急性淋巴细胞白血病/淋巴细胞淋巴瘤患儿接受聚乙二醇化欧文氏菌天冬酰胺酶（pegcrisantaspase）治疗的疗效

期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.26873
Rau, Rachel E; Dreyer, ZoAnn; Choi, Mi Rim; Liang, Wei; Skowronski, Roman; Allamneni, Krishna P; Devidas, Meenakshi; Raetz, Elizabeth A; Adamson, Peter C; Blaney, Susan M; Loh, Mignon L; Hunger, Stephen P
肿瘤
肿瘤免疫
淋巴瘤
白血病
细胞生物学
发表日期：2018
文献求助 收藏

A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas

一项儿科脑肿瘤联盟 II 期试验，研究卡培他滨速溶片联合放射疗法治疗新诊断的弥漫性内生性脑桥胶质瘤患儿的疗效。

期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.26832
Kilburn, Lindsay B; Kocak, Mehmet; Baxter, Patricia; Poussaint, Tina Young; Paulino, Arnold C; McIntyre, Christine; Lemenuel-Diot, Annabelle; Lopez-Diaz, Christine; Kun, Larry; Chintagumpala, Murali; Su, Jack M; Broniscer, Alberto; Baker, Justin N; Hwang, Eugene I; Fouladi, Maryam; Boyett, James M; Blaney, Susan M
胶质瘤
肿瘤
肿瘤免疫
神经科学
发表日期：2018
文献求助 收藏

A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)

一项针对难治性或复发性实体瘤儿童的新型微管靶向化疗药物甲磺酸艾立布林 (E7389) 的 1 期研究：儿童肿瘤协作组 1 期联盟研究 (ADVL1314)

期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.27066
Schafer, Eric S; Rau, Rachel E; Berg, Stacey; Liu, Xiaowei; Minard, Charles G; D'Adamo, David; Scott, Rachael; Reyderman, Larisa; Martinez, Gresel; Devarajan, Sandhya; Reid, Joel M; Fox, Elizabeth; Weigel, Brenda J; Blaney, Susan M
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study

克唑替尼靶向ALK治疗儿童间变性大细胞淋巴瘤和炎性肌纤维母细胞瘤：一项儿童肿瘤协作组研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2017.73.4830
Mossé, Yael P; Voss, Stephan D; Lim, Megan S; Rolland, Delphine; Minard, Charles G; Fox, Elizabeth; Adamson, Peter; Wilner, Keith; Blaney, Susan M; Weigel, Brenda J
肿瘤
肿瘤免疫
ALK
淋巴瘤
细胞生物学
发表日期：2017
文献求助 收藏

A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)

一项针对第二次或更严重复发的急性淋巴细胞白血病患者，评估替西罗莫司联合强化再诱导化疗的 1 期试验：儿童肿瘤协作组研究 (ADVL1114)

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.14569
Rheingold, Susan R; Tasian, Sarah K; Whitlock, James A; Teachey, David T; Borowitz, Michael J; Liu, Xiaowei; Minard, Charles G; Fox, Elizabeth; Weigel, Brenda J; Blaney, Susan M
白血病
细胞生物学
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏